bristol-myers glp-1 receptor agonist products agonists for individualized treatment of type 2 diabetes mellitus Glucagon-like peptide-1 receptor agonists and

doi: 10.1056/nejmoa2028395

Whether you receive a prescription depends on the licensed provider's independent clinical judgment, not the platform's decision

Semaglutide (Ozempic, Wegovy) targets one receptor: GLP-1

For instance, Liraglutide, popularly known as Victoza or Saxenda, has been approved specifically for weight loss by the FDA

These factors help guide informed conversation with your provider about which alternative may align with your metabolic needs, cost constraints, and tolerance profile

The American Diabetes Association Standards of Care advises caution when using these agents in patients with gastroparesis